Senti Biosciences Holdings, Inc.
SNTI
$0.97
-$0.01-0.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.00K | -- | -- | -- | -- |
| Cost of Revenue | 37.59M | 37.60M | 35.74M | 34.86M | 34.36M |
| Gross Profit | -37.56M | -37.60M | -35.74M | -34.86M | -34.36M |
| SG&A Expenses | 19.01M | 20.53M | 18.78M | 16.21M | 16.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -178.00K | -178.00K | -178.00K | -178.00K | -- |
| Total Operating Expenses | 56.42M | 57.95M | 54.34M | 50.90M | 51.23M |
| Operating Income | -56.39M | -57.95M | -54.34M | -50.90M | -51.23M |
| Income Before Tax | -61.44M | -47.58M | -58.32M | -54.79M | -52.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.44 | -47.58 | -58.32 | -54.79 | -52.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.44M | -47.58M | -58.32M | -54.79M | -52.79M |
| EBIT | -56.39M | -57.95M | -54.34M | -50.90M | -51.23M |
| EBITDA | -52.76M | -54.27M | -50.62M | -47.12M | -47.39M |
| EPS Basic | -3.19 | -3.34 | -8.95 | -10.84 | -12.08 |
| Normalized Basic EPS | -1.88 | -1.75 | -2.84 | -4.04 | -4.82 |
| EPS Diluted | -3.19 | -3.34 | -8.95 | -10.84 | -12.08 |
| Normalized Diluted EPS | -1.88 | -1.75 | -2.84 | -4.04 | -4.82 |
| Average Basic Shares Outstanding | 89.70M | 66.98M | 45.33M | 23.82M | 18.38M |
| Average Diluted Shares Outstanding | 89.70M | 66.98M | 45.33M | 23.82M | 18.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |